Company Information

  

Address: 600 MADISON AVENUE, SUITE 1601  
City: NEW YORK 
State: NY 
Zip Code: 10022-1737 
Telephone: 302 355-0650 

Description of Business

Primary SIC Code: 2834
(As filed with the SEC)  

iBio is a biotechnology company focused on using our proprietary technologies and production facilities to provide product development and manufacturing services to clients, collaborators and third-party customers as well as developing and commercializing our own product candidates. Our assets and capabilities include proprietary and transformative methods for the development, improvement, and production of biologics in hydroponically grown, transiently-transfected green plants. We harness the natural protein production capability plants use to sustain their own growth, and direct it, instead, to produce proteins for a range of applications including vaccines, biopharmaceuticals and commercial intermediates, and also to create and produce proprietary derivatives of pre-existing products with improved properties.  ... More ...  

Per Share Overview

Date 12-mos Rolling EPS Dividend P/E Ratio
06/2017-0.16NAN/E
03/2017-0.14NAN/E
12/2016-0.14NAN/E
09/2016-0.13NAN/E
06/2016-0.12NAN/E
03/2016-0.11NAN/E
12/2015-0.10NAN/E
09/2015-0.09NAN/E

Key Financial Ratios and Statistics

FYE: 06/30

Profitability 2017 Leverage 2017
Net Inc/Comm Equity-0.18Total Liab/Total Assets0.75
Net Inc/Total Assets-0.40Total Liab/Inv Cap0.80
Net Inc/Inv Cap-0.43Total Liab/Comm Equity0.33
Pretax Inc/Net Sales-40.96Interest Coverage Ratio-7.37
Net Inc/Net Sales-36.88Curr Debt/Equity0.02
Cash Flow/Net Sales-33.41LTD/Equity2.81
SG&A/NetSales26.78Total Debt/Equity2.83
Asset Utilization   Liquidity  
Net Receivables Turnover1.01Quick Ratio4.25
Inventory TurnoverNACurrent Ratio4.26
Inventory Day SalesNANet Rec/Curr Assets0.02
Net Sales/Work Cap0.06Inv/Curr Assets0.00
Net Sales/PP&E0.02  

Income Statement (Millions)

  6/30/2017 3/31/2017 12/31/2016 9/30/2016
Total Revenues(Net Sales) 0.15 0.04 0.08 0.14
Cost of Goods Sold NA NA NA NA
Selling & Admin Exps 2.89 2.84 2.35 2.47
Operating Income -3.86 -3.94 -3.33 -3.15
Interest Exp 0.48 0.48 0.48 0.48
Pretax Income -4.33 -4.41 -3.79 -3.61
Other Income 0.01 0.01 0.02 0.03
Net Income Bef Extraordinary ... NA NA NA NA
Net Income -4.33 -3.91 -3.23 -3.06

Balance Sheet (Millions)

Assets 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Cash & Short Term Investments 8.09 12.42 16.33 20.10
Receivables - Total 0.18 0.13 0.10 0.23
Inventories - Total 0.03 0.06 0.03 0.00
Total Current Assets 8.57 12.98 16.75 20.46
Net Property, Plant & Equipment 25.59 25.79 25.45 25.58
Total Assets 36.01 40.70 44.19 48.09
Liabilities        
Accounts Payable 1.67 2.35 1.64 2.00
Debt in Current Liabilities 0.18 0.18 0.18 0.17
Total Current Liabilities 2.01 2.62 1.87 2.17
Long-Term Debt 25.08 25.13 25.18 25.22
Total Liabilities 27.10 27.75 40.04 40.95
Stockholder's Equity        
Minority Interest 0.00 0.00 12.99 13.56
Preferred Stock 0.00 0.00 0.00 0.00
Common Stock 0.09 0.09 0.09 0.09
Retained Earnings -72.12 -67.79 -63.88 -60.65
Treasury Stock NA NA NA NA
Total Stockholders' Equity 8.91 12.95 4.15 7.14
Total Liabilities and Stockholders' Equity 36.01 40.70 44.19 48.09

Cash Flow Summary (Millions)

Categories 6/30/2017 3/31/2017 12/31/2016 9/30/2016
Net Cash Provided by Operating Activities -3.77 -3.56 -3.56 -2.27
Net Cash Provided by Investing Activities -0.53 -0.30 -0.16 -0.60
Net Cash Provided by Financing Activities -0.04 -0.04 -0.04 -0.04

Annual Summary Data (Millions)

Year Sales Net Income EPS
06/20131.01-6.20-0.13
06/20140.20-3.67-0.06
06/20151.85-6.62-0.09
06/20160.95-9.76-0.12
06/20170.39-14.53-0.16
Growth Rates-20.91----

Stock Ownership

Type Date(Q,M) No. Owners Shares Held (000s) % Own
Institutional09/30/17213,0043.24




Report Date : 10/16/2017

Powered By Edgar Online © 2017EDGAR®Online, a division of Donnelley Financial Solutions. EDGAR® is a federally registered trademark of the U.S. Securities and Exchange Commission. EDGAR Online is not affiliated with or approved by the U.S. Securities and Exchange Commission.